Laurus Labs Limited (BOM:540222)
India · Delayed Price · Currency is INR 1,970.35
+34.35 (1.77%)
At close: Sep 11, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 1.06 trillion as of September 11, 2026. Its market cap has increased by 119.85% in one year.
Market Cap
1.06T
Enterprise Value
1.09T
Revenue
72.70B
Ranking
n/a
PE Ratio
97.30
Stock Price
1,970.35
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 1.06T, an increase of 2,142.66%. That is a compound annual growth rate of 37.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.06T | 77.86% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.30B |
| Shilpa Medicare | 188.04B |
| Suven Life Sciences | 94.39B |
| Symbiotec Pharmalab | 72.85B |
| IOL Chemicals and Pharmaceuticals | 61.57B |
| Gujarat Themis Biosyn | 56.13B |
| NGL Fine-Chem | 17.09B |
| Bajaj HealthCare | 11.21B |